10 Firms Hit Hard in Thursday’s Trading

7. Hologic Inc. (NASDAQ:HOLX)

Hologic dropped its share prices on Thursday by 10.10 percent to end at $65.45 apiece amid disappointing earnings results in the first quarter of fiscal year 2025.

In a statement, Hologic said net income in the quarter fell by 18 percent to $201 million from $246.5 million, while revenues were flat at $1.02 billion versus $1.01 billion.

Meanwhile, the company achieved GAAP earnings per share of 87 cents and non-GAAP EPS of $1.03, reaching the high end of guidance.

For the full year, Hologic said it expects revenues to decline to between $4.05 billion and $4.1 billion, but maintained its non-GAAP EPS guidance of $4.25 to $4.35.

Last month, Hologic completed the acquisition of Gynesonics for approximately $350 million.

Hologic is an innovative medical technology company primarily focused on improving women’s health and well-being through early detection and treatment.